Transit Officer Paul DeGeorge thought his son was lying on him. Then he realized something much scarier was happening.
March 18, 2026. More for You ...
Thoracic aortic dissection is often approached as an acute and localised event, and pathological examination has ...
The Lancelot technology delivers enhanced hemodynamics through the integration of precision laser cutting and after ...
Limited launch expected for JenaValve's Trilogy System ...
A patient in the United States has become the first in the country to receive Corcym's next-generation Perceval Plus(R) LANCELOT sutureless aortic valve, marking an important milestone in the ...
In the other project, the research team discovered that NX-1607, a clinical trial drug intended for cancer treatment, has an ...
Is EW a good stock to buy? We came across a bullish thesis on Edwards Lifesciences Corporation Torre Financial Newsletter’s Substack by Federico Torre. In this article, we will summarize the bulls’ ...
The FDA has approved the Trilogy Transcatheter Heart Valve System for treating patients with symptomatic severe aortic ...
JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for ...
Cardiac patients who need life-saving surgical treatment can be heartened by the technological advances that let them live ...